|
|
Drugs for Corticobasal Degeneration (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show all 35)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | cadexomer iodine | | Phase 4 | 514 | | | | 2 | | Pharmaceutical Solutions | | Phase 4 | 7793 | | | | 3 | | Iodine | | Phase 4 | 546 | 7553-56-2 | 807 | | Iodio Iodum Jod Jood Tincture iodine |
| | 4 | | Calamus | Nutraceutical | Phase 4 | 419 | | | | 5 | | Vitamins | | Phase 2, Phase 3 | 5095 | | | | 6 | | Ubiquinone | | Phase 2, Phase 3 | 139 | | | | 7 | | Trace Elements | | Phase 2, Phase 3 | 5802 | | | | 8 | | Micronutrients | | Phase 2, Phase 3 | 5802 | | | | 9 | | Coenzyme Q10 | experimental, Nutraceutical | Phase 2, Phase 3 | 114 | 303-98-0 | 5281915 | (all-E)-2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaenyl)-2,5-Cyclohexadiene-1,4-dione (all-E)-2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-Cyclohexadiene-1,4-dione 2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-Benzoquinone 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl- 2,5-Cyclohexadiene-1,4-dione 4-Ethyl-5-fluoropyrimidine Aqua Q 10L10 Aqua Q10 Bio-Quinon Bio-Quinone Q10 CoQ10 Coenzyme Q-10 Coenzyme Q10 Ensorb Kaneka Q10 | Kudesan Li-Q-Sorb Liquid-Q Neuquinon Neuquinone PureSorb Q 40 Q 10AA Q-Gel Q-Gel 100 Ubidecarenone Ubiquinone 10 Ubiquinone 50 Ubiquinone Q10 Ubiquinone-10 Unbiquinone Unispheres Q 10 |
| | 10 | | Dextromethorphan | approved | Phase 2 | 129 | 125-71-3 | 5360696, 5362449 | ( )-3-Methoxy-N-methylmorphinon ( )-cis-1,3,4,9,10,10a-Hexahydro-6-methoxy-11-methyl-2H-10,4alpha-iminoethanophenanthren (+)-3-Methoxy-17-methylmorphinan (+)-dextromethorphan (-)-3-Methoxy-N-methylmorphinan (9alpha,13alpha,14alpha)-17-methyl-3-(methyloxy)morphinan 125-69-9 (hydrobromide) 125-70-2 125-71-3 18046-32-7 18609-21-7 (hydrochloride) 3-Methoxy-17-methyl-9alpha,13alpha,14alpha-morphinan 3-Methoxy-17-methylmorphinan 32062-10-5 4-21-00-01367 (Beilstein Handbook Reference) 6700-34-1 (hydrobromide, mono-hydrate) 9alpha,13alpha,14alpha-Morphinan, 3-methoxy-17-methyl- (8CI) AC-13098 AC1L1EYT Albutussin Antussan BA 2666 BPBio1_000503 BRD-K33211335-337-03-7 BRN 0088549 BSPBio_000457 Balminil DM Balminil DM Children Bayer Select Flu Relief Bayer Select Head & Chest Cold Bayer Select Night Time Cold Benylin Adult Formula Cough Suppressant Benylin DM Benylin DM (TN) Benylin DM 12 Hour Benylin DM for Children Benylin DM for Children 12 Hour Benylin Pediatric Cough Suppressant C06947 CHEBI:128891 CHEBI:4470 CHEBI:580686 CHEMBL22207 CHEMBL52440 CID3008 CID5360696 CID5362449 Calmylin #1 Canfodion Cerose-DM Chloraseptic DM Contac Day & Night Cold/Flu Day Caplets Contac Jr. Non-drowsy Formula Contac Nighttime Cold Medicine Contac Severe Cold Formula Maximum Strength Contac Severe Cold Formula Non-Drowsy Coricidin Syrup Cosylan Cough-X Creo-Terpin D-Methorphan D-Methorphan Hydrobromide D-methorphan D03742 DB00514 DEA No. 9210 DM DXM Delsym Delsym Cough Formula Delta-Methorphan Demorphan Demorphan Hydrobromide Demorphan hydrobromide Demorphine Destrometerfano Destrometerfano [DCIT] Destrometerfano [Dcit] Dex Dextromethorfan Dextromethorfan [Czech] Dextromethorphan Dextromethorphan (USP) Dextromethorphan Bromhydrate Dextromethorphan Bromide Dextromethorphan [USP:INN:BAN] Dextromethorphan hydrobromide OROS Tablets Dextromethorphan hydrobromide [BAN:JAN] Dextromethorphan hydrobromide monohydrate Dextromethorphane Dextromethorphane [INN-French] Dextromethorphanum Dextromethorphanum [INN-Latin] Dextrometorfano Dextrometorfano [INN-Spanish] Dextrometorphan Dextromorphan Dextrométhorphane Dexyromethorphan Diabe-Tuss DM Syrup | Dimacol Dimetapp DM Dormetan Dormethan Drixoral Cough Drixoral Cough & Congestion Drixoral Cough & Sore Throat EINECS 204-751-7 EINECS 204-752-2 Endotussin-NN Endotussin-NN Pediatric HMS2090C08 HSDB 3056 Hihustan M. Hold Hold DM Koffex DM L-Methorphan LS-91837 LS-91838 Levomethorphan Levomethorphan [BAN:DCF:INN] Levomethorphan [Ban:Dcf:Inn] Levomethorphan [INN:BAN:DCF] Levomethorphane Levomethorphane [INN-French] Levomethorphanum Levomethorphanum [INN-Latin] Levometorfano Levometorfano [INN-Spanish] Lopac-D-2531 Lopac0_000337 MLS000758303 Medicon Methorate Methorate Hydrobromide Methorphan Metrorat MolPort-003-940-943 MolPort-004-285-957 Morphinan, 3-methoxy-17-methyl-, (9-alpha,13-alpha,14-alpha)- (9CI) NCGC00015333-01 NCGC00015333-02 NCGC00015333-04 NCGC00162126-01 Naldecon-DX Novahistex DM Novahistine DM Ornex Severe Cold Formula Orthoxicol PediaCare 1 PediaCare Cough-Cold Formula Pertussin CS Children's Strength Pertussin DM Extra Strength Prestwick0_000359 Prestwick1_000359 Prestwick2_000359 Prestwick3_000359 Prestwick_686 RACEMETHORPHAN Robitussin CF Robitussin Cold & Cough Robitussin Cough Calmers Robitussin DM Robitussin Maximum Strength Cough Robitussin Maximum Strength Cough Suppressant Robitussin Pediatric Robitussin Pediatric Cough Robitussin Pediatric Cough & Cold Robitussin Pediatric Cough Suppressant Robitussin Pediatric Night Relief Romilar Rondec dm Ru-Tuss Expectorant SPBio_002378 St. Joseph Cough Syrup Sucrets 4 Hour Cough Suppressant Sudafed Cough Syrup Triaminic Triaminic DM Long Lasting for Children Trind-DM Trocal Tusilan Tussade Tussar DM Tussi-Organidin Tussi-Organidin DM NR Tussi-Organidin DM-S NR Tylenol Cold No Drowsiness Tylenol Cold and Flu Multi-Symptom Tylenol Cold and Flu No Drowsiness Tylenol Cough + Decongestant Liquid Tylenol Cough Liquid Tylenol Flu No Drowsiness Gelcaps UNII-7355X3ROTS Vicks 44 Cough Relief Viro-Med d-Methorphan delta-Methorphan dextromethorphan l-Methorphan | |
| | 11 | | Quinidine | approved | Phase 2 | 44 | 56-54-2 | 441074 | (+)-quinidine (-)-Quinine (8R,9S)-Quinidine (R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol (S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol (S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol 11010-73-4 12239-42-8 128544-03-6 130-89-2 130-95-0 1407-83-6 21480-31-9 22600_FLUKA 22620_FLUKA 22620_SIGMA 50-54-4 500225-45-6 549-56-4 55980-20-6 56-54-2 572-59-8 6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol 6119-70-6 6151-39-9 6151-40-2 6183-68-2 6591-63-5 6912-57-8 72646-90-3 767303-40-2 804-63-7 840482-04-4 845886-64-8 857212-53-4 864908-93-0 875538-34-4 882741-47-1 883881-01-4 888714-03-2 890027-24-4 894767-09-0 898813-59-7 898814-00-1 898814-28-3 899813-83-3 900786-66-5 900789-95-9 906550-97-8 909263-47-4 909767-48-2 909882-78-6 910878-25-0 910880-97-6 910899-51-3 911445-75-5 918778-04-8 AB00514657 AC1L199L AC1L1ANE AC1L1LHL AC1L1R7Y AC1L3RNZ AC1L9AHT AC1L9AHW AC1LCUGN AC1LDI43 AC1LDI46 AC1MBNAI AC1MHDEF AC1MHUCH AC1MHWS7 AC1MI1Q5 AC1NSV55 AC1NSV58 AC1NSZYR AC1NSZYU AC1NUNML AC1NUNMO AC1NX8JM AC1O56R7 AC1O7EE0 AC1O7GNZ AC1OAH7Z AC1OCD5W AC1OCD62 AC1OFCPL AC1Q4EZ5 AC1Q4EZ6 AC1Q58AF AR-1A4833 AR-1H2065 Aflukin Apo-Quinidine Auriquin BB_NC-0697 BIB1110 BIDD:GT0144 Biquin Durules C06526 C06527 C20H24N2O2 CCRIS 5755 CCRIS 672 CHEBI:111177 CHEBI:15854 CHEBI:28593 CHEMBL170 CHEMBL21578 CHEMBL576997 CHEMBL601807 CHEMBL97 CID10448938 CID1065 CID25522 CID2728270 CID3000825 CID3032576 CID3034034 CID3036746 CID441073 CID441074 CID5317111 CID5317112 CID5320867 CID5320868 | CID5484444 CID5484450 CID5748152 CID5953 CID637552 CID6453100 CID6602154 CID6604605 CID667448 CID667449 CID6857801 CID6916033 CID6916036 CID7048767 CID8549 CID94175 CID9967055 CIN-QUIN CPD000857275 Cardioquin Chinidin Chinidine Chinidinum Chinin Chinine Cin-Quin Coccinine Coco-Quinine Conchinin Conchinine Conquinine D08458 D08460 DB00468 DB00908 Duraquin Epiquinidine FT-0082277 GNF-PF-5459 GNF-Pf-180 GNF-Pf-5423 HMS1304I22 HMS1607A11 HMS1989J09 HMS2089E05 HSDB 225 HSDB 2501 I14-3348 I14-3397 IBS-L0034250 IDI1_000134 KBio1_000134 KBio2_001392 KBio2_003960 KBio2_006528 KBio3_001551 KST-1A1085 Kinidin Kinidin (TN) L001278 LS-141252 LS-187236 LS-194958 LS-221 LS-4562 LT00645788 Lopac-Q-0875 Lopac-Q-1250 MLS001304041 MLS001335913 MLS001335914 NCI-C56246 NCI60_004320 NINDS_000134 NSC 192949 NSC 5362 NSC131458 NSC192949 NSC5362 NSC667852 Novoquinidin OR28880 Pitayin Pitayine Q0006 Q3625_SIGMA Quin-Release Quinact Quinaglute Quinaglute Dura-Tabs Quinalan Quinate Quinatime Quindan Quindine Quinicardine Quinidex Quinidex Extentabs Quinidina Quinidine Quinidine Gluconate Quinidine Sulfate Quiniduran Quinimax Quinine Quinine Dab Quinora Quniacridine RH01857 SAM002264644 SB01652 SMP1_000254 SMR000718748 SMR000857275 SPBio_001375 SPBio_002379 ST056282 TCMDC-131239 TNP00086 alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol beta-Quinine bmse000511 chinidinum chininum quinidina quinidine quinina β-quinine |
| | 12 | | Guaifenesin | approved, vet_approved | Phase 2 | 616 | 93-14-1 | 3516 | 3-(2-Methoxyphenoxy)-1,2-propanediol 3-(O-Methoxyphenoxy)-1,2-propanediol 3-(O-Methoxyphenoxy)-propanediol-1,2 3-O-Methoxyphenoxypropane 1:2-diol Actifed C Aeronesin Amonidren Amonidrin Aresol Benylin-E Bronchol Glycerin ether Glycerin guaiacolate Glycero-guaiacol ether Glycerol a-(2-methoxyphenyl) ether Glycerol a-(O-methoxyphenyl)ether Glycerol a-guaiacyl ether Glycerol a-guiacyl ether Glycerol a-monoguaiacol ether Glycerol guaiacolate Glycerol mono(2-methoxyphenyl) ether Glycerol-a-guajakolether Glycerol-alpha-guajakolether Glyceryl guaiacol Glyceryl guaiacol ether Glyceryl guaiacolate Glyceryl guaiacolate ether Glyceryl guaiacyl ether Glyceryl guaicolate Glyceryl guiacolate | Glycerylguaiacol Guaiacol glycerol ether Guaiacol glyceryl ether Guaiacolglicerinetere Guaiacuran Guaiacurane Guaiacyl glyceryl ether Guaiamar Guaianesin Guaicol glycerine ether Guaicol glyceryl ether Guaifenesin Guaifenesine Guaiphenesin Guaiphenesine Guaiphesin Hustosil Methoxypropanediol Methphenoxydiol Metossipropandiolo O-Methoxyphenyl glyceryl ether Organidin NR Pneumomist Propanosedyl Reduton Robitussin a-Glyceryl guaiacol ether a-Glyceryl guaiacolate ether alpha-Glyceryl guaiacol ether alpha-Glyceryl guaiacolate ether guaiphenesin p-Cresyl acetate |
| | 13 | | Radiopharmaceuticals | | Phase 2 | 485 | | | | 14 | | Fluorodeoxyglucose F18 | | Phase 2 | 392 | | | | 15 | | Central Nervous System Depressants | | Phase 1, Phase 2 | 12806 | | | | 16 | | Antidepressive Agents | | Phase 1, Phase 2 | 2666 | | | | 17 | | Tranquilizing Agents | | Phase 1, Phase 2 | 4164 | | | | 18 | | Lithium carbonate | | Phase 1, Phase 2 | 232 | 554-13-2 | | | 19 | | Psychotropic Drugs | | Phase 1, Phase 2 | 6279 | | | | 20 | | Antimanic Agents | | Phase 1, Phase 2 | 790 | | | | 21 | | Respiratory System Agents | | Phase 2 | 4818 | | | | 22 | | Neurotransmitter Agents | | Phase 2 | 17734 | | | | 23 | | Quinidine gluconate | | Phase 2 | 44 | | | | 24 | | Antitussive Agents | | Phase 2 | 520 | | | | 25 | | Chlorpheniramine, phenylpropanolamine drug combination | | Phase 2 | 616 | | | | 26 | | Excitatory Amino Acid Antagonists | | Phase 2 | 1282 | | | | 27 | | Excitatory Amino Acids | | Phase 2 | 1297 | | | | 28 | | taxane | | Phase 1 | 344 | | | | 29 | | Pramipexole | approved, investigational | | 139 | 104632-26-0 | 59868, 119570 | (-)-Pramipexole (6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine (6S)-N(6)-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine (6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine (S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole (S)-N 6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine 104632-26-0 111GE001 2-amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole 2-amino-6-propylaminotetrahydrobenzothiazole AC1L3P1T BIDD:GT0250 C10H17N3S CHEBI:8356 CHEMBL301265 CID119570 CPD000449298 D05575 DivK1c_006916 Furfuryl Acetate HMS2051A21 HMS2090C15 KBio1_001860 KBio2_002340 KBio2_004908 | KBio2_007476 KBioSS_002343 LS-40722 MLS000758250 MLS001423952 Mirapex MolPort-003-849-957 NCGC00167441-01 Pramipexol Pramipexol [Spanish] Pramipexole Pramipexole (USAN/INN) Pramipexole 2HCl Monohydrate Pramipexole [USAN:INN] Pramipexole hydrochloride Pramipexolum Pramipexolum [Latin] SAM001247006 SBB070477 SMR000449298 SND-919 SUD919CL2Y SpecPlus_000820 Spectrum5_001453 Spectrum_001838 U-98528E pramipexole |
| | 30 | | Levodopa | approved | | 388 | 59-92-7 | 6047 | (-)-(3,4-Dihydroxyphenyl)alanine (-)-3-(3,4-Dihydroxyphenyl)-L-alanine (-)-3-(3,4-dihydroxyphenyl)-L-alanine (-)-Dopa (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid (−)-3-(3,4-dihydroxyphenyl)-L-alanine (−)-dopa .Beta.-(3, 4-Dihydroxyphenyl)alanine .Beta.-(3,4-Dihydroxyphenyl)-L-alanine 1E83F927-C221-46AA-B90A-81B33C5F3868 2-Amino-3-(3,4-dihydroxyphenyl)propanoic acid 23734-74-9 25525-15-9 3, 4-Dihydroxy-L-phenylalanine 3, 4-Dihydroxyphenylalanine 3,4-DIHYDROXYPHENYLALANINE 3,4-Dihydroxy-L-phenylalanine 3,4-Dihydroxyphenyl-L-alanine 3,4-Dihydroxyphenylalanine 3,4-Dihydroxyphenylalanine (VAN) 3,4-dihydroxy-L-phenylalanine 3,4-dihydroxyphenylalanine 3-(3,4-Dihydroxypheny 3-(3,4-Dihydroxyphenyl)-L-alanine 3-Hydroxy-L-tyrosine 34241-25-3 37830_FLUKA 587-45-1 59-92-7 72572-99-7 72573-00-3 88250-23-1 90638-38-3 AC-11686 AC1L1LOR AC1Q4U7F BIDD:GT0158 BPBio1_000059 BSPBio_000053 BSPBio_002354 Bendopa Bio-0575 Biodopa Brocadopa C00355 C9H11NO4 CAS-59-92-7 CCRIS 3766 CHEBI:15765 CHEMBL1009 CID6047 Cerepap Cidandopa D 9628 D00059 D0600 D9628 D9628_SIGMA DAH DB01235 DOPA Deadopa Dihydroxy-L-phenylalanine Dihydroxyphenylalanine DivK1c_000452 Dopa Dopaflex Dopaidan Dopal Dopal-Fher Dopal-fher Dopalina Dopar Dopar (TN) Doparkine Doparl Dopasol Dopaston Dopaston SE Dopastone Dopastral Dopicar Doprin EINECS 200-445-2 EU-0100454 Eldopal Eldopar Eldopatec Eurodopa HMS1568C15 HMS1922J14 HMS2090O08 HMS2093N04 HMS501G14 HSDB 3348 Helfo DOPA | Helfo-Dopa Helfo-dopa IDI1_000452 IV Levodopa InChI=1/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14 Insulamina KBio1_000452 KBio2_000934 KBio2_003502 KBio2_006070 KBioGR_001177 KBioSS_000934 L Dopa L(-)-Dopa L-(-)-Dopa L-(3, 4-Dihydroxyphenyl)-.alpha.-alani L-(3, 4-Dihydroxyphenyl)alanine L-(o-Dihydroxyphenyl)alanine L-.Beta.-(3,4-Dihydroxyphenyl)alanine L-3,4-Dihydroxyphenylalanine L-3,4-dihydroxyphenylalanine L-3-(3,4-Dihydroxyphenyl)-Alanine L-3-(3,4-Dihydroxyphenyl)alanine L-3-Hydroxytyrosine L-4-5-Dihydroxyphenylalanine L-DOPA L-DOPA, Parcopa, Atamet, Stalevo, Madopar, Prolopa, Dopar, 3,4-Dihydroxyphenylalanine, Levodopa L-Dihydroxyphenylalanine L-Dopa L-O-Dihydroxyphenylalanine L-b-(3,4-Dihydroxyphenyl)-a-alanine L-beta-(3,4-Dihydroxyphenyl)-alpha-alanine L-beta-(3,4-Dihydroxyphenyl)alanine L-o-Hydroxytyrosine LS-255 Laradopa Larodopa Ledopa Levedopa Levodopa Levodopa (JP15/USP) Levodopa (JP15/USP/INN) Levodopa [USAN:INN:BAN:JAN] Levodopum Levodopum [INN-Latin] Levopa Lopac-D-9628 Lopac0_000454 MLS000028514 Maipedopa MolPort-000-856-937 NCGC00015384-01 NCGC00016270-01 NCGC00016270-06 NCGC00093869-04 NINDS_000452 NSC 118381 NSC118381 PDSP1_001541 PDSP2_001525 Parda Pardopa Prestwick0_000017 Prestwick1_000017 Prestwick2_000017 Prestwick3_000017 Prestwick_185 Prodopa Ro 4-6316 S1726_Selleck SDCCGMLS-0066924.P001 SMR000058312 SPBio_000391 SPBio_001974 SPECTRUM2300205 Sobiodopa Spectrum2_000496 Spectrum4_000539 Spectrum5_001899 Spectrum_000454 Syndopa UNII-46627O600J Veldopa Weldopa b-(3,4-Dihydroxyphenyl)-L-alanine b-(3,4-Dihydroxyphenyl)-a-L-alanine b-(3,4-Dihydroxyphenyl)alanine beta-(3,4-Dihydroxyphenyl)-L-alanine beta-(3,4-Dihydroxyphenyl)-alpha-L-alanine beta-(3,4-Dihydroxyphenyl)-alpha-alanine beta-(3,4-Dihydroxyphenyl)alanine bmse000322 component of Sinemet l)-L-alanine nchembio.2007.55-comp26 nchembio.89-comp9 ne β-(3,4-dihydroxyphenyl)alanine | |
| | 31 | | Ropinirole | approved, investigational | | 73 | 91374-20-8, 91374-21-9 | 5095, 497540 | 1,3-Dihydro-4-(2-(dipropylamino)ethyl)-2H-indol-2-one monohydrochloride 2(H)-Indol-2-one, 4-(2-(dipropylamino)ethyl)-1,3-dihydro-, monohydrochloride 2H-Indol-2-one, 1,3-dihydro-4-(2-(dipropylamino)ethyl)-, monohydrochloride 2H-Indol-2-one, 4-[2-(dipropylamino)ethyl]-1,3-dihydro-, hydrochloride (1:1) 4-(2-(Dipropylamino)ethyl)-2-indolinone monohydrochloride 4-[2-(Dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one 4-[2-(Dipropylamino)ethyl]indoline-2-one 4-[2-(dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one hydrochloride 4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one 4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one hydrochloride 91374-20-8 91374-20-8 (hydrochloride) 91374-21-9 91374-21-9 (Parent) AB1004799 AC-735 AC1L1JLL AC1L2ABS AC1Q3EQJ AR-1L3132 Adartrel BIDD:GT0826 BRD-K15933101-003-01-2 C07564 CHEBI:8888 CHEMBL1200411 CHEMBL589 CID5095 CID68727 D00784 D08489 DB00268 EU-0101101 HMS2093K04 I06-0692 I06-0693 JZP-7 L000520 LS-83828 LS-83890 Lopac-R-4152 Lopac0_001101 | MolPort-003-666-598 MolPort-003-987-439 NCGC00015893-01 NCGC00015893-04 NCGC00094373-01 NCGC00096064-01 NCGC00096064-02 NVD-434 R 4152 ReQuip ReQuip CR ReQuip LP ReQuip XL ReQuip XR Repreve Requip (TN) Ropinirol Ropinirol [INN-Spanish] Ropinirole Ropinirole (INN) Ropinirole HCl Ropinirole [INN:BAN] Ropinirole hydrochloride Ropinirole hydrochloride (JAN/USAN) Ropinirole hydrochloride [USAN] Ropinirolum Ropinirolum [INN-Latin] Ropitor Ropitor (TN) SK&F 101468 SK&F 101468-A SK&F-101,468 SK&F-101468-A SK&F-101468A SKF 101468 SKF 101468-A SPECTRUM1505178 ST51051236 TL8005858 TL8005859 UNII-030PYR8953 UNII-D7ZD41RZI9 ropinirol | |
| | 32 | | Carbidopa | approved | | 177 | 28860-95-9 | 34359, 38101 | (-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid (-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methylpropanoic acid (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid hydrate (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid monohydrate (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid--water (1/1) (S)-(-)-carbidopa (S)-(-)-carbidopa hydrate (S)-(−)-carbidopa (S)-alpha--Hydrazino-3,4-dihydroxy-alpha--methyl-benzenepropanoic acid monohydrate (S)-carbidopa (S)-carbidopa hydrate (alphaS)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid (alphaS)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate (αS)-α-hydrazino-3,4-dihydroxy-α-methylbenzenepropanoic acid 27925-91-3 28860-95-9 31823-41-3 38821-49-7 AC-1676 AC1L1RFR AC1L1Z32 AC1Q5QGW Atamet BB_SC-5095 Benzenepropanoic acid, alpha-hydrazino-3,4-dihydroxy-alpha-methyl-, monohydrate, (S) C-126 C-DOPA C126_SIGMA C1335_SIGMA CCRIS 5093 CHEBI:3395 CHEBI:39585 CHEMBL1200748 CHEMBL1201236 CID34359 CID38101 CPD-11550 Carbidopa (anhydrous) Carbidopa Anhydrous Carbidopa Monohydrate Carbidopa [USAN:INN:BAN] Carbidopa anhydrous Carbidopa hydrate Carbidopa, (S)-Isomer Carbidopa, Entacapone, & Levodopa Carbidopa-1-wasser | Carbidopum Carbidopum [INN-Latin] DB00190 EINECS 249-271-9 EU-0100382 HMS2089B12 Hadrazino-alpha-methyldopa Hydrocinnamic acid, (-)-L-alpha-hydrazino-3,4-dihydroxy-alpha-methyl-, monohydrate KINSON, 3-(3,4-DIHYDROXY-PHENYL)-2-HYDRAZINO-2-METHYL-PROPIONIC ACID L-3-(3,4-Dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid L-3-(3,4-dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid L-alpha-(3,4-dihydroxybenzyl)-alpha-hydrazinopropionic acid monohydrate L-alpha-Methyl-alpha-hydrazino-beta-(3,4-dihydroxyphenylpropionic acid L-alpha-Methyl-beta-(3,4-dihydroxyphenyl)-alpha-hydrazinopropionic acid L-alpha-Methyldopahydrazine L-α-methyldopahydrazine LS-77199 Lodosin Lodosyn Lodosyn, Carbidopa Lopac0_000382 MK 486 MK-485 MK-486 MLS000069628 MLS002207014 Methyldopahydrazine MolPort-003-940-629 MolPort-005-934-181 N-Aminomethyldopa NCGC00024596-01 NCGC00024596-03 NCGC00024596-05 NCGC00024596-06 S(-)-CARBIDOPA S(-)-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate S-(-)-Carbidopa S-(-)-alpha-Hydrazino-3,4-dihydroxy-2-methylbenzenepropanoic acid S1891_Selleck SMP1_000057 SMR000058235 ST055523 Stalevo Tocris-0455 UNII-KR87B45RGH UNII-MNX7R8C5VO alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid alpha-Methyldopahydrazine carbidopa carbidopum monohydricum |
| | 33 | | Entacapone | approved, investigational | | 51 | 130929-57-6 | 5281081 | (2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide (E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide (E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-N,N-diethyl-prop-2-enamide (E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide (E)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide (e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide 116314-67-1 130929-57-6 2-Cyano-N,N-diethyl-3-(3,4-dihydroxy-5-nitrophenyl)propenamide AC-393 AC1NQY02 BIDD:GT0026 C071192 C07943 C14H15N3O5 CHEBI:4798 CHEMBL953 CID5281081 COM-998 Comtan Comtan (TN) Comtess D00781 | DB00494 ENTACAPONE Entacapona Entacapona [INN-Spanish] Entacapone Entacapone (JAN/USAN/INN) Entacapone [USAN:INN] Entacapone [Usan:Inn] Entacaponum Entacaponum [INN-Latin] HMS2089O16 KB475572 LS-123327 LS-172316 MolPort-003-847-054 N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide NCGC00164555-01 Novartis brand of entacapone OR 611 OR-611 Orion brand of entacapone UNII-4975G9NM6T entacapone | |
| | 34 | | Amantadine | approved | | 67 | 768-94-5 | 2130 | 1-Adamantamine 1-Adamantanamine 1-Adamantanamine (8CI) 1-Adamantylamine 1-Aminoadamantane 1-Aminotricyclo(3.3.1.1(sup 3,7))decane 1-adamantanamine 1-adamantylamine 1-aminoadamantane 138576_ALDRICH 665-66-7 (hydrochloride) 768-94-5 AB00514655 AC-11992 AC1L1CZI AC1Q4UAF AC1Q5396 ADAMANTANE,1-AMINO AKOS000113994 AKOS000119324 Adamantamine Adamantanamine Adamantylamine Amant Amantadina Amantadina [INN-Spanish] Amantadine Amantadine (INN) Amantadine Base Amantadine HCL Amantadine Hydrochloride Amantadine [INN:BAN] Amantadinum Amantadinum [INN-Latin] Amantidine Ambap768-94-5 Aminoadamantane BIA4304 BIDD:GT0757 BPBio1_000368 BRN 2204333 BSPBio_000334 BSPBio_001570 BSPBio_001822 Bio-0821 C06818 C10H17N CHEBI:2618 CHEMBL660 CID2130 D07441 DB00915 DivK1c_000815 EINECS 212-201-2 Endantadine Gen-Amantadine HMS1791O12 HMS1989O12 HSDB 3202 I14-1101 IDI1_000815 InChI=1/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H KBio1_000815 KBio2_000390 | KBio2_002958 KBio2_005526 KBio3_001322 KBioGR_000548 KBioSS_000390 L000868 LS-157049 Lopac-A-1260 Lopac0_000004 Mantadine MolPort-001-661-700 MolPort-001-760-587 MolPort-001-791-102 NCGC00015036-01 NCGC00015036-07 NCGC00162039-01 NCGC00162039-02 NCGC00162039-03 NCGC00162039-04 NCGC00179597-01 NCIOpen2_001059 NINDS_000815 NSC 341865 NSC341865 NSC83653 OR14310 Oprea1_248648 Pk-Merz Pk-merz Prestwick0_000407 Prestwick1_000407 Prestwick2_000407 Prestwick3_000407 SPBio_000002 SPBio_002273 STK298781 Spectrum2_000081 Spectrum3_000291 Spectrum4_000134 Spectrum5_000772 Spectrum_000030 Symadine Symmetrel TCMDC-125869 TL8005280 Tricyclo(3.3.1.1(3,7))-decan-1-amine Tricyclo(3.3.1.1(sup 3,7))decan-1-amine Tricyclo(3.3.1.1(sup 3.7))decan-1-amine Tricyclo(3.3.1.13,7)decan-1-amine Tricyclo[3.3.1.1(3,7)]decan-1-amine Tricyclo[3.3.1.1(3,7)]decan-1-ylamine Tricyclo[3.3.1.1(3,7)]decane-1-amine Tricyclo[3.3.1.1(sup3,7)]decan-1-amine Tricyclo[3.3.1.1^3,7]decan-1-amine UNII-BF4C9Z1J53 Viregyt Virosol WLN: L66 B6 A B- C 1B ITJ BZ Wiregyt adamantan-1-amine adamantan-1-ylamine amantadine amantadine hydrochloride tricyclo[3.3.1.1(3,7)]decan-1-ylamine tricyclo[3.3.1.1(3,7)]decane-1-amine tricyclo[3.3.1.1~3,7~]decan-1-amine |
| | 35 | | Vaccines | | | 6428 | | |
Interventional clinical trials: (show all 26)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | DaTSCAN Imaging in Aging and Neurodegenerative Disease | Enrolling by invitation | NCT01453127 | Phase 4 | | 2 | Effects of Coenzyme Q10 in PSP and CBD | Completed | NCT00532571 | Phase 2, Phase 3 | | 3 | A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration | Completed | NCT00703677 | Phase 1, Phase 2 | | 4 | Electrical Polarization of the Brain in Corticobasal Syndrome | Completed | NCT00273897 | Phase 2 | | 5 | The Differential Diagnosis of Parkinson's Disease and Parkinsonism by Positron-emission Tomography | Completed | NCT01824056 | Phase 2 | | 6 | Safety, Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition | Recruiting | NCT02534038 | Phase 2 | | 7 | Davunetide (AL-108) in Predicted Tauopathies - Pilot Study | Active, not recruiting | NCT01056965 | Phase 2 | | 8 | Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers | Completed | NCT02167594 | Phase 1 | | 9 | Safety Study of TPI-287 to Treat CBS and PSP | Active, not recruiting | NCT02133846 | Phase 1 | | 10 | Innovative Biomarkers in Alzheimer's Disease and Frontotemporal Dementia (FTD): Preventative and Personalized | Unknown status | NCT01403519 | | | 11 | Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration | Completed | NCT01174771 | | | 12 | Study of Tongue Pressures | Completed | NCT00013832 | | | 13 | PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK | Recruiting | NCT02778607 | | | 14 | 4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2 | Recruiting | NCT02966145 | | | 15 | Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) | Recruiting | NCT02365922 | | | 16 | Study for the Early Diagnosis of Parkinson's Disease | Recruiting | NCT02283073 | | | 17 | Parkinson's Disease, Diagnostic Observations (PADDO) | Recruiting | NCT01249768 | | | 18 | Gait Analysis in Neurological Disease | Recruiting | NCT02994719 | | | 19 | ADDIA Proof-of-Performance Clinical Study | Recruiting | NCT03030586 | | | 20 | Diagnosing Frontotemporal Lobar Degeneration | Recruiting | NCT02964637 | | | 21 | Genetic Characterization of Movement Disorders and Dementias | Recruiting | NCT02014246 | | | 22 | 4 Repeat Tauopathy Neuroimaging Initiative | Active, not recruiting | NCT01804452 | | | 23 | Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders, PD,Essential Tremor, (ET),Cortical Basal Degeneration, (CBD),Multiple Systems Atrophy (MSA), Magnetoencephalography | Active, not recruiting | NCT02132052 | | | 24 | The Sunnybrook Dementia Study: Mapping Brain Changes in Alzheimer's, Vascular and Other Dementias | Active, not recruiting | NCT01800214 | | | 25 | Vaccination Uptake (VAX) in PD | Not yet recruiting | NCT02874274 | | | 26 | SudoScan as a Biomarker of Parkinson's Disease | Not yet recruiting | NCT02767037 | |
|
